Compugen Ltd. (CGEN) vs Eledon Pharmaceuticals, Inc. (ELDN)
A side-by-side comparison of Compugen Ltd. and Eledon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEN
Compugen Ltd.
$2.28HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
ELDN
Eledon Pharmaceuticals, Inc.
$2.52HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
Total return — CGEN vs ELDN
growth of $100 · dividends reinvested · last 10yCGEN -63.7% (-9.6%/yr)ELDN -99.0% (-37.2%/yr)CGEN compounded faster over this window
Log scale — wide-divergence pair
CGEN ELDN
CGEN vs ELDN: by the numbers
- •CGEN is the larger company ($215M vs $194M market cap).
- •CGEN is profitable (47.55% net margin) while ELDN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CGEN | ELDN |
|---|---|---|
| P/E ratio | 6.06 | N/A |
| P/S ratio | 2.91 | N/A |
| P/B ratio | 2.42 | 5.88 |
Profitability
| Metric | CGEN | ELDN |
|---|---|---|
| Gross margin | 86.89% | 0.00% |
| Operating margin | 40.94% | 0.00% |
| Net margin | 47.55% | 0.00% |
| ROE | 39.66% | -136.83% |
| ROIC | 26.14% | -74.02% |
Growth (annualized)
| Metric | CGEN | ELDN |
|---|---|---|
| Revenue CAGR (5Y) | 105.91% | N/A |
| Total return CAGR (5Y) | -18.39% | -15.17% |
Frequently asked
- Is CGEN or ELDN more profitable?
- CGEN runs the higher net margin — CGEN at 47.55% versus ELDN at 0.00%.
- How have CGEN and ELDN total returns compared?
- Over the past 10 years, CGEN delivered -9.42% and ELDN delivered -37.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Compugen P/E ratioCompugen ROEEledon Pharmaceuticals ROECompugen operating marginEledon Pharmaceuticals operating marginCompugen revenue growthEledon Pharmaceuticals revenue growthCompugen free cash flowEledon Pharmaceuticals free cash flow
Compugen & Eledon Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.